Biotech Values

[walldiver]

Turnaround stocks: ACHN, ADLR, AEZS, CGPI, CEGE, CVTX, ENCY, FVRL, IDIX, INSM, JAV, NABI, OPXA, PANC, PCYC, SCLN, and YMI.

I included revenue generators CGPI, CVTX, ENCY, and IDIX since you included VPHM, so I assume they're eligible. I didn't include DSCO because it's not down appreciably from January, but I think it could be considered a turnaround candidate because it's been down for a lot longer than one year, and has a shot at taking off if the FDA finally approves Surfaxin in Q1 2008. If you agree, then we can add DSCO to the above list.